Michael Limbert
9Patents
3h-index
29Co-inventors
53Inventor score
Filing activity: Feb 15, 1985 → Nov 10, 1997
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5958413A | Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor | Human Necessities | 85 | Expired |
| US4762848A | 1,3-thiazoles and their use as immunomodulators | Chemistry; Metallurgy | 5 | Expired |
| US5763397A | Glycopeptides, a process for their preparation and their use | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5459141A | Compounds 31668P and 31668U, a process for their production and their use | Chemistry; Metallurgy | 3 | Expired |
| US4701452A | Use of cephem compounds as immunomodulators | Human Necessities | 2 | Expired |
| US5350753A | Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5405844A | Tetracyclic antibiotics and processes for their preparation | Chemistry; Metallurgy | 2 | Expired |
| US5721208A | Glycopeptides a process for their preparation and their use | Emerging Cross-Sectional Technologies | 1 | Expired |
| US4919932A | Pharmaceutical formulation for the treatment of bacterial infections | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.